La Pediatria di Netter – Sezione 18 – Antonio Delfino Editore

Benvenuto nella sezione online di

La Pediatria di Netter, 2ª ed.

Letture Consigliate

Sezione XVIII

Oncologia

Lisa Wray︎

Leucemia

Rebecca Whitmire

Elgarten C.W, Aplenc R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr . 2020;32(1):57–66.
Hijiya N, Schultz K.R, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood . 2016;127(4):392–399.
Hunger S.P, Mullighan C.G. Acute lymphoblastic leukemia in children. N Engl J Med . 2015;373(16):1541–1552.
Raetz E.A, Teachey D.T. T-cell acute lymphoblastic leukemia. Hematology . 2016;2016(1):580–588.

Linfomi

Kyle B. Lenz

Buhtoiarov I.N. Pediatric lymphoma. Pediatr Rev . 2017;38(9):410–423. doi: 10.1542/pir.2016-0152.
Cairo M.S, Beishuizen A. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol . 2019;185(6):1021–1042. doi: 10.1111/bjh.15764.
Hochberg J, Goldman S.C, Cairo M.S. Lymphoma. In: Kliegman R, Stanton B, St. Geme J.W, Schor N.F, Behrman R.E, Nelson W.E, eds. Nelson Textbook of Pediatrics . 21st ed. Elsevier Saunders; 2019:2656–2666 chap 523.
Howlader N, Noone AM, Krapcho M, et al., (eds). SEER Cancer Statistics Review, 1975–2017. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
McCarten K.M, Nadel H.R, Shulkin B.L, et al. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. Pediatr Radiol . 2019;49:1545–1564. doi: 10.1007/s00247-019-04529-8.

Tumori Cerebrali

Stephanie N. Brosius, Kavita A. Desai, and Amish C. Shah

Barnholtz-Sloan J.S, Ostrom Q.T, Cote D. Epidemiology of brain tumors. Neurol Clin . 2018;36(3):395–419.
Dang M., Phillips P.C.. Pediatric brain tumors. Continuum. 2017;23(6,Neuro-oncology):1727–1757.
Louis D.N, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol . 2021;23(8):1231–1251.
Udaka Y.T, Packer R.J. Pediatric brain tumors. Neurol Clin . 2018;36(3):533–556.

Neuroblastoma

Haley Newman

Aygun N. Biological and genetic features of neuroblastoma and their clinical importance. Curr Pediatr Rev . 2018;14(2):73–90. doi: 10.2174/1573396314666180129101627 PMID: 29380702.
Maris J.M. Recent advances in neuroblastoma. N Engl J Med . 2010;362(23):2202–2211. doi: 10.1056/NEJMra0804577 PMID: 20558371; PMCID: PMC3306838.
Matthay K.K, Maris J.M, Schleiermacher G. Neuroblastoma. Nat Rev Dis Primers . 2016;2:16078. doi: 10.1038/nrdp.2016.78 PMID: 27830764.

Neoplasie Renali

Ajibike Lapite

Ambalavanan M, Geller J.I. Treatment of advanced pediatric renal cell carcinoma. Pediatr Blood Cancer . 2019;66(8):e27766 doi: 10.1002/pbc.27766.
Grover S.B, Antil N, Rajani H, et al. Approach to pediatric renal tumors: an imaging review. Abdom Radiol . 2019;44(2):619–641. doi: 10.1007/s00261-018-1773-z.
Hutzen B, Paudel S.N, Kararoudi MN, Cassady K.A, Lee D.A, Cripe T.P. Immunotherapies for pediatric cancer: current landscape and future perspectives. Cancer Metastasis Rev . 2019;38(4):573–594. doi: 10.1007/s10555-019-09819-z.
Malkan A.D, Loh A, Bahrami A, et al. An approach to renal masses in pediatrics. Pediatrics . 2015;135(1):142–158. doi: 10.1542/peds.2014-1011.
Saltzman A.F, Carrasco A.J, Weinman J, Meyers M.L, Cost N.G. Initial imaging for pediatric renal tumors: an opportunity for improvement. J Urol . 2018;199(5):1330–1336. doi: 10.1016/j.juro.2017.11.076.
Walz A.L, Fernandez C.V, Geller J.I. Novel therapy for pediatric and adolescent kidney cancer. Cancer Metastasis Rev . 2019;38(4):643–655. doi: 10.1007/s10555-019-09822-4.

Neoplasie Ossee

Timothy T. Spear, and Jenna M. Gedminas

Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer . 2003;97(12):3068–3075.
Bernstein M, Kovar H, Paulussen M, et al. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P.A, Poplack D.G, eds. Principles and Practice of Pediatric Oncology . 5th ed. Philadelphia: Lippincott: Williams & Wilkins; 2006:1002–1032.
de Alava E, Gerald W.L. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol . 2000;18(1):204–213.
Gereige R, Kumar M. Bone lesions: benign and malignant. Pediatr Rev . 2010;31(9):355–363.
Grier H.E, Krailo M.D, Tarbell N.J, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med . 2003;348(8):694–701.
Gurney J.G, Swensen A.R, Bulterys M. Malignant bone tumors. In: Ries L.A.G, Smith M.A, Gurney J.G, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub. No 99-4649 . Bethesda, MD: National Cancer Institute, SEER Program; 1999.
Jackson T.M, Bittman M, Granowetter L. Pediatric malignant bone tumors: a review and update on current challenges, and emerging drug targets. Curr Probl Pediatr Adolesc Health Care . 2016;46:213–228.
Link M.L, Gebhardt M.C, Meyers P.A. Osteosarcoma. In: Pizzo P.A, Poplack D.G, eds. Principles and Practice of Pediatric Oncology . 5th ed. Philadelphia: Lippincott: Williams & Wilkins; 2006:1074–1115.
Mirabello L, Troisi R.J, Savage S.A. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer . 2009;115(7):1531–1543.

Rabdomiosarcoma

Jeremy M. Grenier, and Jenna M. Gedminas

Borinstein S.C, Steppan D, Hayahi M. Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer . 2018;65.
Hibbitts E, Chi Y.Y, Hawkins D.S. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children’s Oncology Group. Cancer Med . 2019;8:6437–6448.
Skapek S.X, Ferrari A, Gupta A.A. Rhabdomyosarcoma. Nat Rev Dis Primers . 2019;5:1.

Disordini Istiocitari

Jeremy M. Grenier, and Caroline Diorio

Allen C.E, Beverley P.C.L, Collin M, et al. The coming of age of Langerhans cell histiocytosis. Nat Immunol . 2020;21(1):1–7.
Allen C.E, Merad M, McClain K.L. Langerhans-cell histiocytosis. N Engl J Med . 2018;379(9):856–868.
Canna S.W, Marsh R.A. Pediatric hemophagocytic lymphohistiocytosis. Blood . 2020;135(16):1332–1343.
Rodriguez-Galindo C, Allen C.E. Langerhans cell histiocytosis. Blood . 2020;135(16):1319–1331.

Back